- Health, Nursing, Elderly Care
- Public Health in Brazil
- Renal Transplantation Outcomes and Treatments
- Chronic Lymphocytic Leukemia Research
- Migraine and Headache Studies
- Culinary Culture and Tourism
- Cytomegalovirus and herpesvirus research
- Pneumocystis jirovecii pneumonia detection and treatment
- Dental Implant Techniques and Outcomes
- Heavy Metal Exposure and Toxicity
- Dental Health and Care Utilization
- Trace Elements in Health
- Organ Transplantation Techniques and Outcomes
- Electrospun Nanofibers in Biomedical Applications
- Amazonian Archaeology and Ethnohistory
- Sexual Differentiation and Disorders
- Periodontal Regeneration and Treatments
- Organ Donation and Transplantation
- Attention Deficit Hyperactivity Disorder
- X-ray Spectroscopy and Fluorescence Analysis
- Healthcare Regulation
- Healthcare during COVID-19 Pandemic
- Transcranial Magnetic Stimulation Studies
- Fluoride Effects and Removal
- Indigenous Health and Education
Universidade Federal de São Paulo
2023
Hospital de Santa Maria
1990-2017
Centro Hospitalar Lisboa Norte
2013-2017
Download This Paper Open PDF in Browser Add to My Library Share: Permalink Using these links will ensure access this page indefinitely Copy URL DOI
Introduction: Bruton's tyrosine kinase inhibitor, ibrutinib, was recently approved for treatment-naïve, relapsed/refractory and del(17p)/TP53 mutated chronic lymphocytic leukemia (CLL). Discrepancies between clinical trials routine healthcare are commonly observed in hematology–oncology. We aimed to evaluate the real-world characteristics drug-related toxicities of patients with CLL treated ibrutinib Portugal. Methods: conducted a multicenter (13 institutions) retrospective observational...
ABSTRACT Objective: Verify the clinical efficacy and safety of a low-cost tDCS device, in trial for major depressive disorder. Methods: 168 persons were recruited; 32 depressed individuals with moderate or severe symptoms (HDRS17 scores higher than 18) included randomized (16 each group). The intervention consisted 10 active anodal sessions at 2 mA 30 minutes over left dorsolateral prefrontal cortex; sham. main outcome was HDRS17; secondary outcomes satisfaction (TSQM II) quality life...